Yersinia enterocolitica - Xen25 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the parental strain WS2589. Y. enterocolitica-Xen25 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.
Please enter valid quantity
Please login to add favorites
NULL OR EMPTY CART
You successfully added item(s) to your cart
For laboratory use only. This product is intended for animal research only and not for use in humans.
Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. PerkinElmer's bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers.
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro:
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo:
|Gram Positive Gram Negative||Gram negative|
|Luciferase Classification||Bacterial luciferase|
|Optical Imaging Classification||Bioluminescence Imaging|
|Product Brand Name||XenoLight|
|Therapeutic Area||Bacterial infection|
|Unit Size||1 agar plate|